🇺🇸 FDA
Patent

US 12213977

Methods and compositions for treating melanoma

granted A61KA61K31/437A61K31/517

Quick answer

US patent 12213977 (Methods and compositions for treating melanoma) held by The Regents of the University of California expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/437, A61K31/517, A61K35/17, A61K45/06